According to PetIQ's latest financial reports the company has C$0.11 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | C$0.15 B | 12.32% |
2022-12-31 | C$0.13 B | 35.78% |
2021-12-31 | C$0.10 B | 137.23% |
2020-12-31 | C$42.65 M | 19.76% |
2019-12-31 | C$35.61 M | -60.6% |
2018-12-31 | C$90.39 M | 89.73% |
2017-12-31 | C$47.64 M | 4522.41% |
2016-12-31 | C$1.03 M | -77.14% |
2015-12-31 | C$4.5 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
![]() Onconova Therapeutics ONTX | C$22.51 M | -80.52% | ๐บ๐ธ USA |
![]() OPKO Health
OPK | C$0.59 B | 418.24% | ๐บ๐ธ USA |